Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.625,45
1,17%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ bioAffinity Technologies Inc (BIAF) bioAffinity Technologies Inc (BIAF) Notizie

bioAffinity Technologies Inc

BIAF
2,08
-0,21 (-9,17%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202414:00BWbioAffinity Technologies News Update
24/4/202414:00BWbioAffinity Technologies Advances New Product Development..
09/4/202414:00BWbioAffinity Technologies Expands Campaign to Support..
01/4/202415:49BWbioAffinity Technologies Reports Fourth Quarter and Full..
08/3/202423:00EDGAR2Form 8-K - Current report
08/3/202419:15PRNUSWallachbeth Capital Announces Closing of bioAffinity..
08/3/202418:45BWbioAffinity Technologies Announces Closing of $2.5 Million..
08/3/202418:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/3/202403:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/3/202416:45PRNUSWallachBeth Capital Announces Pricing of BioAffinity..
06/3/202415:46BWbioAffinity Technologies Announces Pricing of $2.5 Million..
05/3/202423:26EDGAR2Form 8-K - Current report
05/3/202414:00BWbioAffinity Technologies Reports Accelerating Sales Growth..
21/2/202414:00BWbioAffinity Technologies News Update
06/2/202414:00BWMedical Director of Lung Innovations Network and The Lung..
02/2/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:05EDGAR2Form 8-K - Current report
30/1/202414:00BWbioAffinity Technologies In The News
25/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202414:00BWbioAffinity Technologies Announces Award of Therapeutic..
08/1/202414:00BWbioAffinity Technologies In the News
08/12/202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/12/202314:45EDGAR2Form 8-K - Current report
05/12/202314:00BWbioAffinity Technologies Appoints Jamie Platt, Ph.D., to its..
30/11/202315:20EDGAR2Form 8-K - Current report
30/11/202314:00BWCMS Posts Final Payment Determination for bioAffinity..
28/11/202322:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202314:00BWbioAffinity Technologies VP David Elzi, Ph.D., Named to..
28/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
16/11/202323:23EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202323:07EDGAR2Form 8-K - Current report
15/11/202314:00BWbioAffinity Technologies Teams with American Cancer Society..
14/11/202322:01BWbioAffinity Technologies Reports Third Quarter 2023..
14/11/202321:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202314:00BWbioAffinity Technologies Names Dallas J. Coleman as National..
03/11/202321:49EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202321:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
18/10/202323:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/10/202323:27EDGAR2Form 8-K - Current report
10/10/202314:00BWbioAffinity Technologies to Present at the 8th Annual Dawson..
10/10/202312:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/9/202322:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/9/202323:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
20/9/202323:29EDGAR2Form S-1 - General form for registration of securities under..
Apertura: 2,24 Min: 2,03 Max: 2,2511
Chiusura: 2,29

La tua Cronologia

NASDAQ
BIAF
bioAffinity Technologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network